CVE-2026-105464IBM® Db2® is vulnerable to a local attacker with DBADM authorization gaining elevated privileges due to improper privilege management
Updated under an hour ago ()
Does this affect you?
It affects IBM Db2. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.09%, higher than 1% of scored CVEs.
Do this next
Free account, 1 product
IBM Db2 11.5.0 through 11.5.9, and 12.1.0 through 12.1.5 for Linux, UNIX and Windows (includes DB2 Connect Server) could allow a local attacker to gain elevated privileges due to improper privilege management.
- CVSS
- 8.8 HIGH (v3.1, CNA)CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
- Weakness (CWE)
- CWE-269
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.09% (percentile 1)
- Assigned by
- ibm
- NVD analysis
- Awaiting Analysis
- Record last updated
- Oct 13, 2026
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
IBM Db2 ibm:db2 | from 11.5.0 through 11.5.9; from 12.1.0 through 12.1.5 | CNA record |
References
- https://www.ibm.com/support/pages/node/7291613vendor-advisory, patch
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.